Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Topiramate Tablet, Film Coated
Product Images NDC 72162-2480
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72162-2480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This text provides data on the cumulative rates for time to first seizure based on a comparison between two groups: one group taking Topiramate 50 mg/day (N=234) and the other group taking Topiramate 400 mg/day (N=236). The p-value is 0.0002, indicating a statistically significant difference in the time to first seizure between the two groups. The graph shows the time in days on the x-axis and the cumulative rate on the y-axis for each group.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
Image (B609e53c 2d69 4437 B2a1 9f322208eb27 565 2)
Label (Lbl721622480)
This is a package insert for Topiramate tablets containing 25 mg of the active ingredient. The instructions include storage conditions, caution for dispensing, and the requirement for patients to receive a Medication Guide. The package insert also provides a QR code for accessing additional product literature and the Medication Guide. The tablets are manufactured by Unichem Laboratories Ltd. and repackaged by Bryant Ranch Prepack, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
